| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipose Tissue | 40 | 2022 | 3312 | 5.800 |
Why?
|
| Bone Marrow | 28 | 2022 | 2910 | 5.570 |
Why?
|
| Body Composition | 47 | 2024 | 2422 | 4.920 |
Why?
|
| Bone Density | 50 | 2023 | 3551 | 4.430 |
Why?
|
| Tomography, X-Ray Computed | 67 | 2024 | 20556 | 2.960 |
Why?
|
| Obesity | 54 | 2024 | 12938 | 2.930 |
Why?
|
| Gastrectomy | 18 | 2024 | 672 | 2.780 |
Why?
|
| Abdominal Fat | 8 | 2020 | 221 | 2.700 |
Why?
|
| Anorexia Nervosa | 20 | 2022 | 1361 | 2.660 |
Why?
|
| Radius | 10 | 2023 | 441 | 2.630 |
Why?
|
| Bone Neoplasms | 17 | 2023 | 2529 | 2.610 |
Why?
|
| Human Growth Hormone | 14 | 2022 | 638 | 2.180 |
Why?
|
| Magnetic Resonance Imaging | 79 | 2023 | 36423 | 2.160 |
Why?
|
| Bone and Bones | 17 | 2023 | 2568 | 2.110 |
Why?
|
| Adipose Tissue, Brown | 9 | 2019 | 764 | 2.020 |
Why?
|
| Absorptiometry, Photon | 28 | 2023 | 1737 | 1.980 |
Why?
|
| Arthrography | 7 | 2021 | 150 | 1.930 |
Why?
|
| Fluorodeoxyglucose F18 | 18 | 2022 | 2010 | 1.900 |
Why?
|
| Awards and Prizes | 3 | 2023 | 360 | 1.830 |
Why?
|
| Intra-Abdominal Fat | 11 | 2022 | 612 | 1.750 |
Why?
|
| Femoracetabular Impingement | 5 | 2021 | 179 | 1.590 |
Why?
|
| Adiposity | 19 | 2021 | 1877 | 1.570 |
Why?
|
| Obesity, Morbid | 11 | 2024 | 1277 | 1.550 |
Why?
|
| Joint Diseases | 7 | 2019 | 459 | 1.540 |
Why?
|
| Premenopause | 11 | 2016 | 1039 | 1.530 |
Why?
|
| Lumbar Vertebrae | 19 | 2023 | 1881 | 1.490 |
Why?
|
| Whole Body Imaging | 11 | 2022 | 283 | 1.320 |
Why?
|
| Obesity, Abdominal | 6 | 2017 | 374 | 1.320 |
Why?
|
| Osteoporosis | 4 | 2024 | 1605 | 1.280 |
Why?
|
| Fasting | 6 | 2023 | 1602 | 1.270 |
Why?
|
| Spinal Neoplasms | 4 | 2022 | 716 | 1.270 |
Why?
|
| Radiology | 6 | 2024 | 2113 | 1.260 |
Why?
|
| Femur | 14 | 2023 | 1307 | 1.260 |
Why?
|
| Muscle, Skeletal | 15 | 2022 | 4946 | 1.240 |
Why?
|
| Fractures, Bone | 6 | 2023 | 2046 | 1.230 |
Why?
|
| Hip Joint | 8 | 2021 | 1013 | 1.170 |
Why?
|
| Magnetic Resonance Spectroscopy | 10 | 2016 | 3769 | 1.160 |
Why?
|
| Neurofibromatosis 1 | 11 | 2022 | 560 | 1.120 |
Why?
|
| Young Adult | 85 | 2024 | 59207 | 1.090 |
Why?
|
| Sarcopenia | 2 | 2022 | 372 | 1.090 |
Why?
|
| Insulin-Like Growth Factor I | 16 | 2023 | 1931 | 1.080 |
Why?
|
| Humans | 275 | 2024 | 761423 | 1.070 |
Why?
|
| Femur Neck | 2 | 2021 | 314 | 1.070 |
Why?
|
| Adult | 163 | 2024 | 221148 | 1.060 |
Why?
|
| Cartilage Diseases | 5 | 2019 | 157 | 1.050 |
Why?
|
| Female | 196 | 2024 | 392581 | 1.030 |
Why?
|
| Elbow Joint | 5 | 2022 | 359 | 1.010 |
Why?
|
| Ischium | 4 | 2014 | 28 | 1.000 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 2 | 2018 | 180 | 0.990 |
Why?
|
| Tibia | 12 | 2023 | 1070 | 0.980 |
Why?
|
| Overweight | 13 | 2024 | 2413 | 0.980 |
Why?
|
| Bone Diseases | 2 | 2019 | 418 | 0.970 |
Why?
|
| Adolescent | 83 | 2024 | 88313 | 0.950 |
Why?
|
| Wrist Injuries | 3 | 2023 | 214 | 0.930 |
Why?
|
| Arthroscopy | 9 | 2017 | 968 | 0.920 |
Why?
|
| Bariatric Surgery | 6 | 2024 | 992 | 0.910 |
Why?
|
| Bone Cysts, Aneurysmal | 3 | 2022 | 70 | 0.900 |
Why?
|
| Lipid Metabolism | 7 | 2018 | 1902 | 0.880 |
Why?
|
| Cumulative Trauma Disorders | 3 | 2019 | 151 | 0.870 |
Why?
|
| Hip Injuries | 2 | 2014 | 79 | 0.870 |
Why?
|
| Middle Aged | 124 | 2024 | 220826 | 0.860 |
Why?
|
| Hip | 3 | 2014 | 255 | 0.860 |
Why?
|
| Musculoskeletal Diseases | 2 | 2019 | 598 | 0.850 |
Why?
|
| Insulin Resistance | 14 | 2024 | 3963 | 0.820 |
Why?
|
| Adrenal Cortex Hormones | 5 | 2022 | 1876 | 0.820 |
Why?
|
| Knee Joint | 6 | 2023 | 1673 | 0.810 |
Why?
|
| Male | 145 | 2024 | 360736 | 0.800 |
Why?
|
| Arthralgia | 5 | 2015 | 461 | 0.800 |
Why?
|
| Soft Tissue Neoplasms | 8 | 2019 | 1159 | 0.800 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2024 | 257 | 0.790 |
Why?
|
| Subcutaneous Fat, Abdominal | 3 | 2017 | 91 | 0.780 |
Why?
|
| Muscular Diseases | 4 | 2018 | 553 | 0.760 |
Why?
|
| Positron-Emission Tomography | 15 | 2022 | 6485 | 0.760 |
Why?
|
| Diagnostic Imaging | 4 | 2023 | 3530 | 0.760 |
Why?
|
| Neurofibromatoses | 6 | 2018 | 299 | 0.750 |
Why?
|
| Gastric Bypass | 6 | 2024 | 818 | 0.750 |
Why?
|
| Musculoskeletal System | 3 | 2019 | 188 | 0.740 |
Why?
|
| Perivascular Epithelioid Cell Neoplasms | 2 | 2018 | 77 | 0.720 |
Why?
|
| Radiopharmaceuticals | 11 | 2021 | 2651 | 0.720 |
Why?
|
| Faculty | 1 | 2023 | 383 | 0.700 |
Why?
|
| Chordoma | 3 | 2020 | 347 | 0.690 |
Why?
|
| Opportunistic Infections | 1 | 2023 | 376 | 0.680 |
Why?
|
| Sarcoma | 4 | 2019 | 1801 | 0.670 |
Why?
|
| Tendon Injuries | 7 | 2019 | 328 | 0.660 |
Why?
|
| Tendons | 4 | 2022 | 558 | 0.660 |
Why?
|
| Multiple Myeloma | 5 | 2021 | 5146 | 0.660 |
Why?
|
| Liver | 8 | 2023 | 7532 | 0.660 |
Why?
|
| Physicians, Women | 2 | 2024 | 508 | 0.650 |
Why?
|
| Injections, Intra-Articular | 6 | 2022 | 280 | 0.640 |
Why?
|
| Lipids | 7 | 2022 | 3340 | 0.640 |
Why?
|
| Acromegaly | 2 | 2020 | 310 | 0.620 |
Why?
|
| Osteoarthritis, Hip | 4 | 2021 | 406 | 0.620 |
Why?
|
| Gadolinium DTPA | 3 | 2020 | 823 | 0.600 |
Why?
|
| Hemangiosarcoma | 1 | 2020 | 215 | 0.600 |
Why?
|
| Lumbosacral Region | 2 | 2016 | 293 | 0.600 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 3 | 2018 | 68 | 0.590 |
Why?
|
| Sensitivity and Specificity | 25 | 2018 | 14664 | 0.590 |
Why?
|
| Lipid Metabolism Disorders | 1 | 2017 | 20 | 0.590 |
Why?
|
| Injections | 1 | 2020 | 830 | 0.580 |
Why?
|
| Radiography, Interventional | 5 | 2019 | 1121 | 0.580 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2019 | 3356 | 0.570 |
Why?
|
| Retrospective Studies | 50 | 2024 | 80582 | 0.560 |
Why?
|
| Spinal Fractures | 5 | 2020 | 705 | 0.550 |
Why?
|
| Rupture | 7 | 2022 | 443 | 0.550 |
Why?
|
| Synovial Cyst | 1 | 2016 | 35 | 0.550 |
Why?
|
| Neurofibroma, Plexiform | 3 | 2022 | 66 | 0.540 |
Why?
|
| Aged | 68 | 2024 | 169235 | 0.540 |
Why?
|
| Anesthetics, Local | 3 | 2019 | 997 | 0.540 |
Why?
|
| Collateral Ligaments | 2 | 2010 | 34 | 0.540 |
Why?
|
| Contrast Media | 11 | 2020 | 5311 | 0.530 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2024 | 942 | 0.530 |
Why?
|
| Growth Hormone | 3 | 2023 | 569 | 0.520 |
Why?
|
| Psoas Muscles | 1 | 2016 | 66 | 0.510 |
Why?
|
| Calcitonin | 1 | 2016 | 329 | 0.500 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2015 | 50 | 0.490 |
Why?
|
| Oxytocin | 3 | 2024 | 402 | 0.490 |
Why?
|
| Faculty, Medical | 5 | 2024 | 1202 | 0.480 |
Why?
|
| Zygapophyseal Joint | 1 | 2016 | 128 | 0.480 |
Why?
|
| Cardiovascular Diseases | 10 | 2022 | 15498 | 0.470 |
Why?
|
| Patient Positioning | 1 | 2017 | 326 | 0.460 |
Why?
|
| Bone Remodeling | 2 | 2016 | 581 | 0.450 |
Why?
|
| Cortisone | 2 | 2024 | 87 | 0.440 |
Why?
|
| Physical Examination | 1 | 2019 | 1254 | 0.440 |
Why?
|
| Pericardium | 1 | 2018 | 675 | 0.430 |
Why?
|
| Shoulder Joint | 3 | 2017 | 742 | 0.430 |
Why?
|
| Fluoroscopy | 4 | 2019 | 947 | 0.430 |
Why?
|
| Adipocytes | 2 | 2017 | 1194 | 0.430 |
Why?
|
| Tomography, Emission-Computed | 3 | 2007 | 1122 | 0.420 |
Why?
|
| Bone Marrow Diseases | 1 | 2015 | 233 | 0.420 |
Why?
|
| Nerve Sheath Neoplasms | 4 | 2022 | 170 | 0.420 |
Why?
|
| Cold Temperature | 3 | 2015 | 786 | 0.420 |
Why?
|
| Pelvis | 1 | 2017 | 732 | 0.420 |
Why?
|
| Femur Head | 3 | 2021 | 297 | 0.410 |
Why?
|
| Burnout, Professional | 1 | 2021 | 704 | 0.400 |
Why?
|
| Peripheral Nervous System Neoplasms | 2 | 2017 | 133 | 0.400 |
Why?
|
| Mentors | 3 | 2023 | 660 | 0.400 |
Why?
|
| Cartilage, Articular | 4 | 2005 | 1099 | 0.400 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2016 | 409 | 0.400 |
Why?
|
| Neurilemmoma | 5 | 2018 | 526 | 0.400 |
Why?
|
| Estrone | 2 | 2023 | 234 | 0.400 |
Why?
|
| Chondroma | 1 | 2012 | 53 | 0.400 |
Why?
|
| Terminology as Topic | 1 | 2019 | 1535 | 0.400 |
Why?
|
| Ultrasonography, Interventional | 2 | 2018 | 1495 | 0.390 |
Why?
|
| Reproducibility of Results | 21 | 2016 | 20093 | 0.390 |
Why?
|
| Protons | 3 | 2015 | 1115 | 0.380 |
Why?
|
| Steroids | 1 | 2016 | 929 | 0.380 |
Why?
|
| Radiography | 7 | 2023 | 6966 | 0.380 |
Why?
|
| Methionine | 2 | 2018 | 572 | 0.380 |
Why?
|
| Sex Characteristics | 3 | 2018 | 2637 | 0.380 |
Why?
|
| Abdomen | 1 | 2017 | 1128 | 0.380 |
Why?
|
| Soft Tissue Injuries | 1 | 2013 | 172 | 0.370 |
Why?
|
| Caregivers | 1 | 2023 | 2237 | 0.370 |
Why?
|
| Neck | 2 | 2016 | 734 | 0.360 |
Why?
|
| Diagnosis, Differential | 14 | 2021 | 12970 | 0.360 |
Why?
|
| Adiponectin | 4 | 2015 | 1113 | 0.360 |
Why?
|
| Curriculum | 1 | 2024 | 3741 | 0.350 |
Why?
|
| Neurofibromatosis 2 | 5 | 2016 | 385 | 0.350 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2012 | 1651 | 0.350 |
Why?
|
| Spine | 4 | 2023 | 1118 | 0.350 |
Why?
|
| Hydrocortisone | 4 | 2024 | 1815 | 0.350 |
Why?
|
| Amenorrhea | 3 | 2021 | 483 | 0.340 |
Why?
|
| Regression Analysis | 8 | 2016 | 6343 | 0.340 |
Why?
|
| Pain | 4 | 2019 | 5071 | 0.340 |
Why?
|
| Aged, 80 and over | 27 | 2020 | 58956 | 0.340 |
Why?
|
| Early Detection of Cancer | 1 | 2024 | 3201 | 0.340 |
Why?
|
| Triglycerides | 4 | 2014 | 2460 | 0.340 |
Why?
|
| Prospective Studies | 19 | 2023 | 54415 | 0.330 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2021 | 9277 | 0.330 |
Why?
|
| Acetabulum | 2 | 2021 | 542 | 0.330 |
Why?
|
| Bone Density Conservation Agents | 1 | 2016 | 795 | 0.320 |
Why?
|
| Mechanical Phenomena | 1 | 2010 | 141 | 0.320 |
Why?
|
| Anthropometry | 3 | 2013 | 1349 | 0.320 |
Why?
|
| Growth Hormone-Releasing Hormone | 2 | 2009 | 128 | 0.320 |
Why?
|
| Subcutaneous Fat | 5 | 2016 | 393 | 0.320 |
Why?
|
| Progesterone | 1 | 2013 | 742 | 0.320 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2013 | 376 | 0.310 |
Why?
|
| Thoracic Vertebrae | 2 | 2016 | 596 | 0.310 |
Why?
|
| Estrogens | 3 | 2021 | 1522 | 0.310 |
Why?
|
| Body Mass Index | 14 | 2022 | 12951 | 0.310 |
Why?
|
| Arthritis, Infectious | 1 | 2012 | 346 | 0.310 |
Why?
|
| Sacrum | 2 | 2023 | 276 | 0.300 |
Why?
|
| Trabecular Meshwork | 1 | 2008 | 101 | 0.300 |
Why?
|
| Giant Cell Tumor of Bone | 2 | 2022 | 118 | 0.300 |
Why?
|
| Tendinopathy | 3 | 2017 | 173 | 0.300 |
Why?
|
| Liposarcoma, Myxoid | 1 | 2007 | 60 | 0.290 |
Why?
|
| Fibrosarcoma | 2 | 2023 | 309 | 0.290 |
Why?
|
| Cross-Sectional Studies | 21 | 2022 | 26112 | 0.290 |
Why?
|
| Extremities | 4 | 2018 | 867 | 0.280 |
Why?
|
| Case-Control Studies | 16 | 2020 | 22168 | 0.280 |
Why?
|
| Hominidae | 2 | 2018 | 68 | 0.280 |
Why?
|
| Sacroiliac Joint | 1 | 2006 | 57 | 0.270 |
Why?
|
| Knee Injuries | 4 | 2018 | 487 | 0.270 |
Why?
|
| Endocrine System Diseases | 1 | 2008 | 249 | 0.270 |
Why?
|
| Fractures, Compression | 1 | 2008 | 131 | 0.270 |
Why?
|
| Hormones | 3 | 2016 | 869 | 0.260 |
Why?
|
| Antihypertensive Agents | 1 | 2015 | 2023 | 0.260 |
Why?
|
| Placebos | 3 | 2017 | 1667 | 0.260 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2009 | 542 | 0.260 |
Why?
|
| Prognosis | 10 | 2023 | 29620 | 0.260 |
Why?
|
| Arginine | 1 | 2009 | 933 | 0.250 |
Why?
|
| Neoplasms | 4 | 2019 | 22164 | 0.250 |
Why?
|
| Range of Motion, Articular | 5 | 2023 | 1586 | 0.250 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2006 | 152 | 0.250 |
Why?
|
| Administration, Intranasal | 2 | 2024 | 477 | 0.250 |
Why?
|
| Metformin | 1 | 2013 | 906 | 0.250 |
Why?
|
| Cone-Beam Computed Tomography | 2 | 2010 | 474 | 0.250 |
Why?
|
| Neurofibroma | 2 | 2022 | 95 | 0.240 |
Why?
|
| Scoliosis | 1 | 2011 | 740 | 0.240 |
Why?
|
| Program Evaluation | 2 | 2024 | 2494 | 0.240 |
Why?
|
| Fractures, Spontaneous | 2 | 2017 | 231 | 0.240 |
Why?
|
| Weight Loss | 7 | 2024 | 2683 | 0.240 |
Why?
|
| Ligaments, Articular | 2 | 2019 | 302 | 0.240 |
Why?
|
| Cerebral Hemorrhage | 1 | 2015 | 2656 | 0.230 |
Why?
|
| Sports | 1 | 2010 | 705 | 0.230 |
Why?
|
| Longitudinal Studies | 7 | 2023 | 14599 | 0.230 |
Why?
|
| Bacterial Infections | 1 | 2012 | 1393 | 0.220 |
Why?
|
| Gene Fusion | 3 | 2021 | 356 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 7389 | 0.220 |
Why?
|
| Myostatin | 1 | 2024 | 129 | 0.220 |
Why?
|
| Radiation Dosage | 4 | 2019 | 1958 | 0.220 |
Why?
|
| Fats | 2 | 2016 | 99 | 0.210 |
Why?
|
| Nerve Compression Syndromes | 2 | 2015 | 160 | 0.210 |
Why?
|
| Finite Element Analysis | 4 | 2019 | 437 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 12143 | 0.210 |
Why?
|
| Buttocks | 2 | 2020 | 111 | 0.210 |
Why?
|
| Osteosarcoma | 3 | 2018 | 897 | 0.200 |
Why?
|
| Double-Blind Method | 7 | 2024 | 12330 | 0.200 |
Why?
|
| Societies, Medical | 3 | 2019 | 3905 | 0.200 |
Why?
|
| Appetite | 2 | 2022 | 247 | 0.200 |
Why?
|
| Foot | 2 | 2018 | 575 | 0.200 |
Why?
|
| Osteoblastoma | 1 | 2022 | 24 | 0.200 |
Why?
|
| Treatment Outcome | 18 | 2024 | 64651 | 0.200 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 13337 | 0.200 |
Why?
|
| Diaphyses | 2 | 2019 | 65 | 0.190 |
Why?
|
| Athletic Injuries | 2 | 2018 | 1216 | 0.190 |
Why?
|
| Glucose | 3 | 2023 | 4347 | 0.190 |
Why?
|
| Prevalence | 8 | 2020 | 15717 | 0.190 |
Why?
|
| Osteoblasts | 2 | 2017 | 1143 | 0.190 |
Why?
|
| Testosterone | 5 | 2023 | 2472 | 0.190 |
Why?
|
| Membrane Proteins | 4 | 2015 | 7856 | 0.190 |
Why?
|
| Risk Assessment | 9 | 2018 | 23990 | 0.190 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 2 | 2012 | 138 | 0.190 |
Why?
|
| Neoplasm Staging | 4 | 2021 | 11106 | 0.190 |
Why?
|
| Bone Cysts | 1 | 2021 | 48 | 0.190 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2016 | 550 | 0.180 |
Why?
|
| Langerhans Cells | 1 | 2021 | 170 | 0.180 |
Why?
|
| Career Mobility | 1 | 2023 | 259 | 0.180 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2023 | 269 | 0.180 |
Why?
|
| Traction | 1 | 2021 | 110 | 0.180 |
Why?
|
| Risk Factors | 18 | 2022 | 74167 | 0.180 |
Why?
|
| Ghrelin | 1 | 2022 | 252 | 0.180 |
Why?
|
| Torsion Abnormality | 1 | 2021 | 91 | 0.180 |
Why?
|
| Pituitary Neoplasms | 2 | 2020 | 1324 | 0.180 |
Why?
|
| Child | 18 | 2023 | 80162 | 0.180 |
Why?
|
| Muscular Atrophy | 2 | 2020 | 333 | 0.180 |
Why?
|
| Chondroblastoma | 1 | 2020 | 47 | 0.180 |
Why?
|
| Chondrosarcoma | 1 | 2023 | 296 | 0.180 |
Why?
|
| Hypoglycemic Agents | 1 | 2013 | 3081 | 0.180 |
Why?
|
| Tennis Elbow | 1 | 1999 | 16 | 0.170 |
Why?
|
| Hypertension | 2 | 2020 | 8542 | 0.170 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2021 | 169 | 0.170 |
Why?
|
| Cell Dedifferentiation | 1 | 2020 | 122 | 0.170 |
Why?
|
| Shoulder Impingement Syndrome | 1 | 1999 | 35 | 0.170 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2021 | 210 | 0.170 |
Why?
|
| Receptors, Somatostatin | 1 | 2020 | 136 | 0.160 |
Why?
|
| Ankle Joint | 1 | 2023 | 445 | 0.160 |
Why?
|
| Berlin | 1 | 2018 | 23 | 0.160 |
Why?
|
| Follow-Up Studies | 8 | 2022 | 39117 | 0.160 |
Why?
|
| Synovitis | 1 | 2000 | 217 | 0.160 |
Why?
|
| Humerus | 1 | 2021 | 272 | 0.160 |
Why?
|
| Receptors, Calcitriol | 1 | 2021 | 360 | 0.160 |
Why?
|
| NFATC Transcription Factors | 1 | 2021 | 389 | 0.160 |
Why?
|
| Injections, Intralesional | 2 | 2016 | 277 | 0.160 |
Why?
|
| Calcaneus | 3 | 2018 | 142 | 0.160 |
Why?
|
| Boston | 7 | 2020 | 9330 | 0.160 |
Why?
|
| Tarsal Bones | 2 | 2018 | 70 | 0.160 |
Why?
|
| Fibula | 1 | 2021 | 266 | 0.160 |
Why?
|
| Sex Factors | 4 | 2018 | 10548 | 0.160 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2021 | 224 | 0.150 |
Why?
|
| Diet, Protein-Restricted | 1 | 2018 | 73 | 0.150 |
Why?
|
| Pandemics | 4 | 2022 | 8641 | 0.150 |
Why?
|
| Femur Head Necrosis | 1 | 2019 | 132 | 0.150 |
Why?
|
| Fossils | 1 | 2018 | 75 | 0.150 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2021 | 455 | 0.150 |
Why?
|
| Tumor Burden | 5 | 2018 | 1890 | 0.150 |
Why?
|
| Brachial Plexus Neuropathies | 1 | 1999 | 122 | 0.150 |
Why?
|
| Fractures, Stress | 1 | 2020 | 202 | 0.150 |
Why?
|
| Neural Conduction | 1 | 1999 | 441 | 0.150 |
Why?
|
| Time Factors | 7 | 2024 | 39975 | 0.150 |
Why?
|
| Water | 2 | 2018 | 1410 | 0.150 |
Why?
|
| Ergolines | 1 | 2017 | 57 | 0.150 |
Why?
|
| Endometrium | 1 | 2000 | 403 | 0.150 |
Why?
|
| Predictive Value of Tests | 8 | 2018 | 15262 | 0.150 |
Why?
|
| Artificial Intelligence | 2 | 2024 | 2578 | 0.150 |
Why?
|
| Shoulder | 1 | 1999 | 300 | 0.150 |
Why?
|
| Femoral Neoplasms | 1 | 2017 | 84 | 0.150 |
Why?
|
| Muscles | 2 | 2014 | 1576 | 0.140 |
Why?
|
| Pectoralis Muscles | 1 | 2018 | 85 | 0.140 |
Why?
|
| Osteocalcin | 2 | 2017 | 274 | 0.140 |
Why?
|
| Pituitary Diseases | 2 | 2016 | 135 | 0.140 |
Why?
|
| Postoperative Period | 3 | 2020 | 1815 | 0.140 |
Why?
|
| Thorax | 1 | 2020 | 555 | 0.140 |
Why?
|
| Research Personnel | 1 | 2022 | 588 | 0.140 |
Why?
|
| Central Cord Syndrome | 1 | 2016 | 5 | 0.140 |
Why?
|
| Leg | 3 | 2011 | 1089 | 0.140 |
Why?
|
| Baseball | 2 | 2008 | 95 | 0.140 |
Why?
|
| Spondylosis | 1 | 2017 | 85 | 0.140 |
Why?
|
| Radiation Protection | 2 | 2017 | 424 | 0.140 |
Why?
|
| Disease Progression | 5 | 2021 | 13502 | 0.140 |
Why?
|
| Social Behavior | 1 | 2023 | 1134 | 0.140 |
Why?
|
| Fibroma | 1 | 2018 | 190 | 0.140 |
Why?
|
| Lipodystrophy | 1 | 2017 | 148 | 0.130 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2017 | 282 | 0.130 |
Why?
|
| Germany | 1 | 2018 | 875 | 0.130 |
Why?
|
| Brain | 2 | 2021 | 27107 | 0.130 |
Why?
|
| Calcinosis | 2 | 2016 | 1469 | 0.130 |
Why?
|
| Liposarcoma | 1 | 2019 | 289 | 0.130 |
Why?
|
| Gene Expression | 2 | 2021 | 7584 | 0.130 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 416 | 0.130 |
Why?
|
| Receptors, Somatotropin | 1 | 2016 | 58 | 0.130 |
Why?
|
| Receptors, GABA | 1 | 2018 | 313 | 0.130 |
Why?
|
| Observer Variation | 4 | 2015 | 2605 | 0.130 |
Why?
|
| Sarcoma, Synovial | 1 | 2017 | 153 | 0.130 |
Why?
|
| Energy Metabolism | 3 | 2024 | 2881 | 0.130 |
Why?
|
| Food | 1 | 2021 | 772 | 0.130 |
Why?
|
| Tarsal Joints | 1 | 2015 | 32 | 0.130 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2016 | 241 | 0.130 |
Why?
|
| Skin Neoplasms | 4 | 2018 | 5819 | 0.130 |
Why?
|
| Somatostatin | 1 | 2017 | 447 | 0.130 |
Why?
|
| Lectins | 1 | 2017 | 491 | 0.130 |
Why?
|
| Foot Joints | 1 | 2015 | 35 | 0.130 |
Why?
|
| Peptides, Cyclic | 1 | 2017 | 392 | 0.130 |
Why?
|
| New York | 1 | 2018 | 874 | 0.130 |
Why?
|
| Cell Size | 1 | 2017 | 624 | 0.120 |
Why?
|
| Pilot Projects | 3 | 2024 | 8633 | 0.120 |
Why?
|
| Neutrophil Infiltration | 1 | 2017 | 389 | 0.120 |
Why?
|
| Starvation | 1 | 2015 | 142 | 0.120 |
Why?
|
| Blood Glucose | 5 | 2017 | 6391 | 0.120 |
Why?
|
| Cardiovascular System | 2 | 2013 | 835 | 0.120 |
Why?
|
| Biopsy | 5 | 2018 | 6766 | 0.120 |
Why?
|
| Cushing Syndrome | 1 | 2016 | 241 | 0.120 |
Why?
|
| Peer Group | 1 | 2020 | 692 | 0.120 |
Why?
|
| Perception | 1 | 2021 | 1197 | 0.120 |
Why?
|
| Academic Medical Centers | 2 | 2024 | 2760 | 0.120 |
Why?
|
| Up-Regulation | 3 | 2021 | 4124 | 0.120 |
Why?
|
| Health Status Disparities | 2 | 2017 | 1852 | 0.120 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 2014 | 131 | 0.120 |
Why?
|
| Venous Insufficiency | 1 | 2016 | 110 | 0.120 |
Why?
|
| Epithelioid Cells | 1 | 2014 | 60 | 0.120 |
Why?
|
| Causality | 3 | 2016 | 1243 | 0.120 |
Why?
|
| Electromyography | 1 | 1999 | 1393 | 0.120 |
Why?
|
| Canada | 1 | 2019 | 2120 | 0.110 |
Why?
|
| Anorexia | 1 | 2014 | 154 | 0.110 |
Why?
|
| Pain Measurement | 5 | 2018 | 3550 | 0.110 |
Why?
|
| Minority Groups | 1 | 2021 | 1203 | 0.110 |
Why?
|
| Comorbidity | 5 | 2019 | 10498 | 0.110 |
Why?
|
| Iliotibial Band Syndrome | 1 | 2013 | 5 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2024 | 8999 | 0.110 |
Why?
|
| Femoral Neuropathy | 1 | 2013 | 7 | 0.110 |
Why?
|
| C-Reactive Protein | 5 | 2015 | 3823 | 0.110 |
Why?
|
| Osteoporotic Fractures | 1 | 2018 | 411 | 0.110 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2017 | 702 | 0.110 |
Why?
|
| Endocrine System | 1 | 2014 | 114 | 0.110 |
Why?
|
| Procollagen | 1 | 2014 | 187 | 0.110 |
Why?
|
| Bursa, Synovial | 1 | 2013 | 25 | 0.110 |
Why?
|
| Tenosynovitis | 1 | 2013 | 57 | 0.110 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2015 | 1411 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 7409 | 0.110 |
Why?
|
| Tongue | 1 | 2016 | 403 | 0.110 |
Why?
|
| Cognition | 3 | 2016 | 6986 | 0.110 |
Why?
|
| Ulna | 1 | 2014 | 134 | 0.110 |
Why?
|
| Thinness | 1 | 2017 | 490 | 0.110 |
Why?
|
| Angiofibroma | 1 | 2013 | 55 | 0.110 |
Why?
|
| Germ-Line Mutation | 2 | 2020 | 1858 | 0.110 |
Why?
|
| Ligaments | 1 | 2013 | 127 | 0.110 |
Why?
|
| Respiratory System | 1 | 2016 | 563 | 0.110 |
Why?
|
| Prednisone | 1 | 2017 | 1562 | 0.100 |
Why?
|
| Sternoclavicular Joint | 1 | 2012 | 32 | 0.100 |
Why?
|
| Congresses as Topic | 1 | 2018 | 803 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 21012 | 0.100 |
Why?
|
| Nutrition Surveys | 1 | 2020 | 1728 | 0.100 |
Why?
|
| Calcium-Binding Proteins | 3 | 2012 | 1069 | 0.100 |
Why?
|
| Bursitis | 1 | 2013 | 80 | 0.100 |
Why?
|
| Glucagon | 1 | 2014 | 532 | 0.100 |
Why?
|
| Dyslipidemias | 1 | 2020 | 868 | 0.100 |
Why?
|
| Atrophy | 2 | 2015 | 1633 | 0.100 |
Why?
|
| Outpatients | 1 | 2020 | 1597 | 0.100 |
Why?
|
| Estradiol | 3 | 2021 | 1937 | 0.100 |
Why?
|
| Myositis Ossificans | 1 | 2013 | 77 | 0.100 |
Why?
|
| Visual Perception | 1 | 2021 | 1385 | 0.100 |
Why?
|
| Apolipoproteins B | 1 | 2014 | 386 | 0.100 |
Why?
|
| Proportional Hazards Models | 3 | 2022 | 12456 | 0.100 |
Why?
|
| S100 Proteins | 1 | 2012 | 218 | 0.100 |
Why?
|
| Wrist Joint | 1 | 2014 | 267 | 0.100 |
Why?
|
| Leadership | 1 | 2021 | 1385 | 0.100 |
Why?
|
| Patella | 1 | 2013 | 314 | 0.100 |
Why?
|
| Feasibility Studies | 2 | 2015 | 5246 | 0.100 |
Why?
|
| Caloric Restriction | 1 | 2014 | 299 | 0.100 |
Why?
|
| Syndrome | 3 | 2018 | 3268 | 0.100 |
Why?
|
| Bone Marrow Cells | 2 | 2017 | 2415 | 0.100 |
Why?
|
| Military Personnel | 1 | 2020 | 1246 | 0.090 |
Why?
|
| Cholesterol, HDL | 2 | 2015 | 1814 | 0.090 |
Why?
|
| Thermogenesis | 1 | 2015 | 475 | 0.090 |
Why?
|
| ROC Curve | 3 | 2020 | 3580 | 0.090 |
Why?
|
| Edema | 1 | 2014 | 767 | 0.090 |
Why?
|
| Vitamin D | 3 | 2013 | 3301 | 0.090 |
Why?
|
| Quality Assurance, Health Care | 1 | 2000 | 2169 | 0.090 |
Why?
|
| Iodide Peroxidase | 1 | 2012 | 294 | 0.090 |
Why?
|
| Mitochondria | 2 | 2013 | 3623 | 0.090 |
Why?
|
| Triiodothyronine | 1 | 2012 | 493 | 0.090 |
Why?
|
| Suicidal Ideation | 1 | 2020 | 1444 | 0.090 |
Why?
|
| Waist Circumference | 2 | 2016 | 934 | 0.090 |
Why?
|
| Tuberous Sclerosis | 1 | 2018 | 1030 | 0.090 |
Why?
|
| Hyperglycemia | 1 | 2018 | 1376 | 0.090 |
Why?
|
| Insulin | 5 | 2023 | 6602 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 1385 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 2298 | 0.080 |
Why?
|
| Nerve Growth Factors | 1 | 2012 | 563 | 0.080 |
Why?
|
| Fibroblast Growth Factors | 1 | 2015 | 867 | 0.080 |
Why?
|
| Preoperative Care | 1 | 2018 | 2242 | 0.080 |
Why?
|
| Molecular Imaging | 1 | 2016 | 815 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2019 | 2161 | 0.080 |
Why?
|
| Anxiety | 2 | 2024 | 4572 | 0.080 |
Why?
|
| Ankle Injuries | 1 | 2013 | 338 | 0.080 |
Why?
|
| Health Promotion | 1 | 2021 | 2213 | 0.080 |
Why?
|
| Skinfold Thickness | 1 | 2008 | 161 | 0.080 |
Why?
|
| Diagnostic Techniques, Endocrine | 1 | 2008 | 43 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 1301 | 0.080 |
Why?
|
| New England | 1 | 2012 | 1053 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 3687 | 0.080 |
Why?
|
| Metatarsalgia | 1 | 2008 | 3 | 0.080 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2011 | 267 | 0.080 |
Why?
|
| Postoperative Complications | 3 | 2022 | 15650 | 0.080 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2013 | 625 | 0.080 |
Why?
|
| Thyrotropin | 1 | 2012 | 834 | 0.080 |
Why?
|
| Thyroxine | 1 | 2012 | 668 | 0.080 |
Why?
|
| Patellar Dislocation | 1 | 2009 | 67 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2020 | 11073 | 0.070 |
Why?
|
| Body Fat Distribution | 1 | 2009 | 245 | 0.070 |
Why?
|
| Adenoma | 1 | 2018 | 2160 | 0.070 |
Why?
|
| Wound Healing | 1 | 2018 | 2803 | 0.070 |
Why?
|
| Athletes | 1 | 2015 | 1136 | 0.070 |
Why?
|
| Memory | 2 | 2016 | 2187 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2009 | 4063 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2017 | 4001 | 0.070 |
Why?
|
| Friction | 2 | 2018 | 59 | 0.070 |
Why?
|
| United States | 3 | 2024 | 72339 | 0.070 |
Why?
|
| Osteogenesis | 1 | 2014 | 1273 | 0.070 |
Why?
|
| Metatarsal Bones | 1 | 2008 | 111 | 0.070 |
Why?
|
| Carbon Isotopes | 1 | 2007 | 458 | 0.070 |
Why?
|
| Incidental Findings | 1 | 2011 | 697 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 4320 | 0.070 |
Why?
|
| Ossification, Heterotopic | 1 | 2009 | 235 | 0.070 |
Why?
|
| Hip Fractures | 1 | 2014 | 988 | 0.070 |
Why?
|
| Rotation | 2 | 2023 | 517 | 0.070 |
Why?
|
| Body Weight | 1 | 2017 | 4618 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 2824 | 0.070 |
Why?
|
| Parathyroid Hormone | 1 | 2012 | 1803 | 0.060 |
Why?
|
| Seasons | 1 | 2012 | 1519 | 0.060 |
Why?
|
| Pyrimidines | 1 | 2018 | 3027 | 0.060 |
Why?
|
| Exercise | 2 | 2013 | 5884 | 0.060 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 1988 | 0.060 |
Why?
|
| Gene Rearrangement | 2 | 2021 | 1125 | 0.060 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 2382 | 0.060 |
Why?
|
| Neutrophils | 1 | 2017 | 3766 | 0.060 |
Why?
|
| Radiology Information Systems | 1 | 2009 | 529 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2017 | 10089 | 0.060 |
Why?
|
| Mass Screening | 1 | 2020 | 5428 | 0.060 |
Why?
|
| Linear Models | 1 | 2014 | 5869 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2019 | 3429 | 0.060 |
Why?
|
| Reference Values | 3 | 2017 | 4921 | 0.060 |
Why?
|
| Algorithms | 2 | 2017 | 14026 | 0.060 |
Why?
|
| Gonadal Hormones | 1 | 2023 | 30 | 0.060 |
Why?
|
| Weight-Bearing | 2 | 2017 | 532 | 0.060 |
Why?
|
| Mice, Inbred C3H | 2 | 2015 | 915 | 0.060 |
Why?
|
| Waist-Hip Ratio | 2 | 2016 | 518 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 2 | 2016 | 1703 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3810 | 0.050 |
Why?
|
| Homeostasis | 2 | 2013 | 3321 | 0.050 |
Why?
|
| Ilium | 1 | 2023 | 155 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2011 | 1201 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2021 | 2510 | 0.050 |
Why?
|
| Blood Pressure | 2 | 2014 | 8487 | 0.050 |
Why?
|
| Leucine | 1 | 2023 | 548 | 0.050 |
Why?
|
| Peptide YY | 1 | 2022 | 136 | 0.050 |
Why?
|
| Fibrosis | 2 | 2022 | 2048 | 0.050 |
Why?
|
| Joint Instability | 1 | 2009 | 801 | 0.050 |
Why?
|
| Child, Preschool | 5 | 2021 | 42254 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2014 | 5115 | 0.050 |
Why?
|
| Periosteum | 1 | 2002 | 139 | 0.050 |
Why?
|
| Quality of Life | 3 | 2022 | 13361 | 0.040 |
Why?
|
| Depression | 1 | 2020 | 8122 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 8000 | 0.040 |
Why?
|
| Scapula | 1 | 2002 | 173 | 0.040 |
Why?
|
| Ankle | 1 | 2023 | 350 | 0.040 |
Why?
|
| Growth Hormone-Secreting Pituitary Adenoma | 1 | 2020 | 49 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 6339 | 0.040 |
Why?
|
| Executive Function | 2 | 2021 | 1389 | 0.040 |
Why?
|
| Brachial Plexus Neuritis | 1 | 1999 | 20 | 0.040 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2022 | 379 | 0.040 |
Why?
|
| Electromagnetic Fields | 1 | 2001 | 296 | 0.040 |
Why?
|
| Glucose Tolerance Test | 2 | 2013 | 1179 | 0.040 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 2734 | 0.040 |
Why?
|
| Florida | 1 | 2020 | 431 | 0.040 |
Why?
|
| Models, Biological | 1 | 2015 | 9469 | 0.040 |
Why?
|
| Triamcinolone | 1 | 2019 | 68 | 0.040 |
Why?
|
| Statistics, Nonparametric | 3 | 2009 | 2851 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2021 | 3639 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 5840 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 4 | 2018 | 22163 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 552 | 0.040 |
Why?
|
| Cohort Studies | 5 | 2018 | 41446 | 0.040 |
Why?
|
| Transcription Factors | 4 | 2021 | 12125 | 0.040 |
Why?
|
| Neoplasm, Residual | 1 | 2002 | 1008 | 0.040 |
Why?
|
| Synovial Membrane | 1 | 2000 | 532 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 368 | 0.030 |
Why?
|
| Ethiopia | 1 | 2018 | 464 | 0.030 |
Why?
|
| Energy Intake | 1 | 2024 | 2134 | 0.030 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2016 | 141 | 0.030 |
Why?
|
| Animals | 9 | 2022 | 168441 | 0.030 |
Why?
|
| Pelvic Neoplasms | 1 | 2018 | 247 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2020 | 1596 | 0.030 |
Why?
|
| Phenotype | 3 | 2020 | 16606 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 682 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2015 | 6841 | 0.030 |
Why?
|
| Iopamidol | 1 | 2016 | 186 | 0.030 |
Why?
|
| Thoracic Neoplasms | 1 | 2018 | 267 | 0.030 |
Why?
|
| Cues | 1 | 2021 | 875 | 0.030 |
Why?
|
| Kinetics | 1 | 2023 | 6374 | 0.030 |
Why?
|
| Adrenal Gland Diseases | 1 | 2016 | 141 | 0.030 |
Why?
|
| Laminectomy | 1 | 2016 | 225 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2016 | 5970 | 0.030 |
Why?
|
| Fracture Fixation | 1 | 2017 | 364 | 0.030 |
Why?
|
| Hallux | 1 | 2015 | 43 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2019 | 568 | 0.030 |
Why?
|
| Mucin-4 | 1 | 2014 | 33 | 0.030 |
Why?
|
| Lipolysis | 1 | 2016 | 212 | 0.030 |
Why?
|
| Fracture Healing | 1 | 2017 | 445 | 0.030 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2014 | 47 | 0.030 |
Why?
|
| Sclerosis | 1 | 2014 | 210 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2021 | 2918 | 0.030 |
Why?
|
| Inflammation | 1 | 2014 | 10762 | 0.030 |
Why?
|
| Incidence | 3 | 2022 | 21341 | 0.030 |
Why?
|
| Telomerase | 1 | 2019 | 745 | 0.030 |
Why?
|
| Lipase | 1 | 2016 | 325 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 1638 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2016 | 539 | 0.030 |
Why?
|
| Hematoma | 1 | 2018 | 768 | 0.030 |
Why?
|
| Ideal Body Weight | 1 | 2012 | 27 | 0.030 |
Why?
|
| Leptin | 2 | 2012 | 1597 | 0.030 |
Why?
|
| Cholesterol | 2 | 2015 | 2902 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2017 | 823 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13637 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 1230 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2018 | 1116 | 0.030 |
Why?
|
| Infant | 2 | 2021 | 36205 | 0.020 |
Why?
|
| Back | 1 | 2012 | 64 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 1934 | 0.020 |
Why?
|
| Osteoclasts | 1 | 2016 | 711 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 2898 | 0.020 |
Why?
|
| Postural Balance | 1 | 2016 | 621 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 6532 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 2416 | 0.020 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1222 | 0.020 |
Why?
|
| Equipment Design | 2 | 2011 | 3509 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2014 | 365 | 0.020 |
Why?
|
| Organ Size | 1 | 2016 | 2254 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2016 | 876 | 0.020 |
Why?
|
| Self Report | 1 | 2022 | 3724 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2013 | 455 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2022 | 2826 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 1626 | 0.020 |
Why?
|
| Cryopreservation | 1 | 2015 | 728 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2014 | 718 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 2016 | 981 | 0.020 |
Why?
|
| Anesthetics | 1 | 2015 | 523 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2021 | 5789 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2012 | 559 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 2916 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2016 | 2358 | 0.020 |
Why?
|
| Histones | 1 | 2020 | 2580 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2023 | 6238 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 4510 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 2525 | 0.020 |
Why?
|
| Neuroma, Acoustic | 1 | 2012 | 459 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 15838 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2015 | 2898 | 0.020 |
Why?
|
| X-Ray Intensifying Screens | 1 | 2008 | 32 | 0.020 |
Why?
|
| Accidental Falls | 1 | 2016 | 1068 | 0.020 |
Why?
|
| Forefoot, Human | 1 | 2008 | 31 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2012 | 2265 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 3589 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2012 | 1118 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2015 | 1808 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2009 | 344 | 0.020 |
Why?
|
| E-Selectin | 1 | 2009 | 576 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2016 | 2908 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 1897 | 0.020 |
Why?
|
| Rotator Cuff | 1 | 2009 | 348 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2021 | 5794 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 5665 | 0.020 |
Why?
|
| Cadaver | 1 | 2010 | 1358 | 0.020 |
Why?
|
| Mutation | 2 | 2020 | 30045 | 0.020 |
Why?
|
| Genotype | 1 | 2020 | 13009 | 0.020 |
Why?
|
| Logistic Models | 1 | 2020 | 13255 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2009 | 1125 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 4912 | 0.020 |
Why?
|
| Hyalin | 1 | 2005 | 34 | 0.020 |
Why?
|
| Mice | 3 | 2017 | 81509 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2019 | 7956 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 8179 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 2018 | 2892 | 0.010 |
Why?
|
| Software | 1 | 2017 | 4434 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 7045 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2016 | 4936 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16979 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2016 | 12796 | 0.010 |
Why?
|
| Shoulder Dislocation | 1 | 2002 | 129 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 2005 | 476 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10441 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2015 | 14409 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2009 | 3207 | 0.010 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 3704 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 17912 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2009 | 2884 | 0.010 |
Why?
|
| Aging | 1 | 2016 | 8705 | 0.010 |
Why?
|
| Massachusetts | 1 | 2009 | 8832 | 0.010 |
Why?
|
| Age Factors | 1 | 2012 | 18400 | 0.010 |
Why?
|